Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate

The syndrome of hepatic veno-occlusive disease after marrow transplantation

1995 • 475 citations

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate

1999 • 458 citations

Treatment of Severe Veno-Occlusive Disease With Defibrotide: Compassionate Use Results in Response Without Significant Toxicity in a High-Risk Population

1998 • 255 citations

Expression of normal myeloid-associated antigens by acute leukemia cells

1986 • 227 citations

THE USE OF RADIOLABELED ANTI-CD33 ANTIBODY TO AUGMENT MARROW IRRADIATION PRIOR TO MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA

1992 • 171 citations

Monoclonal antibodies to the myeloid stem cells: therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate

2000 • 101 citations

Treatment of acute myelogenous leukemia in older adults

2000 • 70 citations

Differences in the frequency of normal and clonal precursors of colony- forming cells in chronic myelogenous leukemia and acute myelogenous leukemia

1992 • 64 citations

Hematopoietic stem cell markers are expressed by ductal plate and bile duct cells in developing human liver

1995 • 57 citations

Antibody-targeted therapy for myeloid leukemia.

1999 • 55 citations